approved

Приложение 4 на ПЛС от 02.08.2020 г.

Unique identificator:  4cf24e0d-723c-4ee6-8f1f-85079e7c20cf

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-08-06 16:31:04
  • Created by: georgi_sivchev
  • Updated at: 2020-08-06 16:31:04
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 120.09 24.02 144.11 4% 4.8 124.89 24.98 149.87 16% 19.21 144.1 28.82 172.92 НСР-8226/22.02.2016 09.03.2016 09.03.2016 Неактивен 3397
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 182.3 36.46 218.76 4% 7.29 189.59 37.92 227.51 16% 25 214.59 42.92 257.51 промяна на обстоятелства НСР-8286/26.02.2016 НСР-5145/27.11.2014 11.12.2014 11.12.2014 Неактивен 3398
Lacosamide EU/1/08/470/011 VIMPAT, Film coated tablet, 200, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 243.07 48.61 291.68 4% 9.72 252.79 50.56 303.35 16% 25 277.79 55.56 333.35 промяна на обстоятелства НСР-8285/26.02.2016 НСР-5146/27.11.2014 11.12.2014 11.12.2014 Неактивен 3399
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 121.57 24.31 145.88 4% 4.86 126.43 25.29 151.72 16% 19.45 145.88 29.18 175.06 промяна на обстоятелства НСР-8259/26.02.2016 НСР-5144/27.11.2014 11.12.2014 11.12.2014 Неактивен 3397
Lacosamide EU/1/08/470/011 VIMPAT, Film coated tablet, 200, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Belgium 256.47 51.29 307.76 4% 10 266.47 53.29 319.76 16% 25 291.47 58.29 349.76 НСР-3083/21.03.2014 08.04.2014 08.04.2014 Неактивен 3399
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Belgium 128.28 25.66 153.94 4% 5.13 133.41 26.68 160.09 16% 20.52 153.93 30.79 184.72 НСР-3081/21.03.2014 08.04.2014 08.04.2014 Неактивен 3397
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Belgium 192.36 38.47 230.83 4% 7.69 200.05 40.01 240.06 16% 25 225.05 45.01 270.06 НСР-3082/21.03.2014 08.04.2014 08.04.2014 Неактивен 3398
Lacosamide EU/1/08/470/011 VIMPAT, Film coated tablet, 200, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 266.68 53.34 320.02 4% 10 276.68 55.34 332.02 16% 25 301.68 60.34 362.02 КЦРР-780/15.06.2012 г 28.12.2012 28.12.2012 Неактивен 3399
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 133.33 26.67 160 4% 5.33 138.66 27.73 166.39 16% 21.33 159.99 32 191.99 КЦРР-780/15.06.2012 г 28.12.2012 28.12.2012 Неактивен 3397
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 200 40 240 4% 8 208 41.6 249.6 16% 25 233 46.6 279.6 КЦРР-780/15.06.2012 г 28.12.2012 28.12.2012 Неактивен 3398
Lacosamide EU/1/08/470/011 VIMPAT, Film coated tablet, 200, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 290.5 58.1 348.6 4% 10 300.5 60.1 360.6 16% 25 325.5 65.1 390.6 КЦ-2060/14.03.2011 29.03.2011 29.03.2011 Неактивен 3399
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 220.17 44.03 264.2 4% 8.81 228.98 45.8 274.78 16% 25 253.98 50.8 304.78 КЦ-2059/14.03.2011 29.03.2011 29.03.2011 Неактивен 3398
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 146.75 29.35 176.1 4% 5.87 152.62 30.52 183.14 16% 23.48 176.1 35.22 211.32 КЦ-2062/14.03.2011 29.03.2011 29.03.2011 Неактивен 3397
Lacosamide EU/1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 14.73 2.95 17.68 6% 0.88 15.61 3.12 18.73 18% 2.65 18.26 3.65 21.91 промяна на обстоятелства НСР-8276/26.02.2016 НСР-6904/06.08.2015.; НСР-10687/21.10.2016; НСР-17736/17.01.2019 01.02.2019 02.02.2019 Активен 3396
Lacosamide EU/1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 14.73 2.95 17.68 6% 0.88 15.61 3.12 18.73 18% 2.65 18.26 3.65 21.91 промяна на обстоятелства НСР-8276/26.02.2016 НСР-6904/06.08.2015.; НСР-10687/21.10.2016; НСР-17736/17.01.2019 01.02.2019 02.02.2019 Неактивен 3396
Lacosamide EU/1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 15.16 3.03 18.19 6% 0.91 16.07 3.21 19.28 18% 2.73 18.8 3.76 22.56 промяна на обстоятелства НСР-8276/26.02.2016 НСР-6904/06.08.2015.; НСР-10687/21.10.2016 08.11.2016 02.12.2016 Неактивен 3396
Lacosamide EU/1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 15.2 3.04 18.24 6% 0.91 16.11 3.22 19.33 18% 2.74 18.85 3.77 22.62 промяна на обстоятелства НСР-8276/26.02.2016 НСР-6904/06.08.2015. 21.08.2015 21.08.2015 Неактивен 3396
Lacosamide EU1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 15.82 3.16 18.98 6% 0.95 16.77 3.35 20.12 18% 2.85 19.62 3.92 23.54 НСР-5136/27.11.2014 11.12.2014 11.12.2014 Неактивен 3396
Lacosamide EU1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 16.02 3.2 19.22 6% 0.96 16.98 3.4 20.38 18% 2.88 19.86 3.97 23.83 НСР-3080/21.03.2014 08.04.2014 08.04.2014 Неактивен 3396
Lacosamide EU1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 16.66 3.33 19.99 6% 1 17.66 3.53 21.19 18% 3 20.66 4.13 24.79 КЦРР-780/15.06.2012 г 28.12.2012 28.12.2012 Неактивен 3396
Lacosamide EU1/08/470/001 VIMPAT, Film coated tablet, 50, mg, Pack: 14 UCB Pharma SA, Белгия UCB Pharma GmbH, Germany 19.03 3.81 22.84 6% 1.14 20.17 4.03 24.2 18% 3.43 23.6 4.72 28.32 КЦ-2056/14.03.2011 29.03.2011 29.03.2011 Неактивен 3396
Vinblastine II-9569/18.08.2004 Vinblastine Teva, Powder and solvent for solution for injection, 10, mg, Pack: 1 Тева Фармасютикълс България ЕООД, България Pharmachemie BV, The Netherlands 7.22 1.44 8.66 7% 0.51 7.73 1.55 9.28 20% 1.44 9.17 1.83 11 цената се заличава HCР-149/12.06.2013 КЦРР-2508/06.03.2013 21.03.2013 21.03.2013 Заличен 1702
Vinblastine II-9569/18.08.2004 Vinblastine Teva, Powder and solvent for solution for injection, 10, mg, Pack: 1 Тева Фармасютикълс България ЕООД, България Pharmachemie BV, The Netherlands; 13.81 2.76 16.57 6% 0.83 14.64 2.93 17.57 18% 2.49 17.13 3.43 20.56 КЦ-833/23.04.2009 02.06.2009 02.06.2009 Неактивен 1702
Vinorelbine 20060823/26.02.2012 Vinorelbin Actavis, Concentrate for solution for infusion, 50, mg, Pack: 1 Актавис EАД, България S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A., Италия 49.99 10 59.99 4% 2 51.99 10.4 62.39 16% 8 59.99 12 71.99 HCР-468/09.07.2013; НСР-19094/27.06.2019 25.07.2013 02.08.2019 Заличен 1973
Vinorelbine 20060823/26.02.2012 Vinorelbin Actavis, Concentrate for solution for infusion, 50, mg, Pack: 1 Актавис EАД, България S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A., Италия 49.99 10 59.99 4% 2 51.99 10.4 62.39 16% 8 59.99 12 71.99 HCР-468/09.07.2013 25.07.2013 25.07.2013 Неактивен 1973
Showing 16726 to 16751 of 17770 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте